BRPI0906357A2 - Derivados de oxazepinopirimidona arilamida substituídos - Google Patents

Derivados de oxazepinopirimidona arilamida substituídos

Info

Publication number: BRPI0906357A2
Authority: BR; Brazil
Prior art keywords: oxazepinopyrimidone; substituted; arylamide derivatives; arylamide; derivatives
Prior art date: 2008-01-29

Application number

BRPI0906357-9A

Other languages

English (en)

Inventor

Aude Fayol

Alistair Lochead

Mourad Saady

Julien Vache

Philippe Yaiche

Original Assignee

Sanofi Aventis

Mitsubishi Tanabe Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-29

Filing date

2009-01-27

Publication date

2015-07-07

2009-01-27 Application filed by Sanofi Aventis, Mitsubishi Tanabe Pharma Corp filed Critical Sanofi Aventis

2015-07-07 Publication of BRPI0906357A2 publication Critical patent/BRPI0906357A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
Psychology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0906357-9A 2008-01-29 2009-01-27 Derivados de oxazepinopirimidona arilamida substituídos BRPI0906357A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08290075A EP2085399A1 (en)	2008-01-29	2008-01-29	substituted arylamide oxazepinopyrimidone derivatives
PCT/IB2009/000298 WO2009095788A1 (en)	2008-01-29	2009-01-27	Substituted arylamide oxazepinopyrimidone derivatives

Publications (1)

Publication Number	Publication Date
BRPI0906357A2 true BRPI0906357A2 (pt)	2015-07-07

Family

ID=39494505

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0906357-9A BRPI0906357A2 (pt)	2008-01-29	2009-01-27	Derivados de oxazepinopirimidona arilamida substituídos

Country Status (16)

Country	Link
US (1)	US8507470B2 (pt)
EP (2)	EP2085399A1 (pt)
JP (1)	JP5581221B2 (pt)
KR (1)	KR20100117582A (pt)
CN (1)	CN101959893A (pt)
AR (1)	AR070263A1 (pt)
AU (1)	AU2009208727A1 (pt)
BR (1)	BRPI0906357A2 (pt)
CA (1)	CA2713253A1 (pt)
EA (1)	EA201070890A1 (pt)
IL (1)	IL207231A0 (pt)
MX (1)	MX2010008361A (pt)
NZ (1)	NZ587067A (pt)
TW (1)	TW200936140A (pt)
WO (1)	WO2009095788A1 (pt)
ZA (1)	ZA201005383B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2090579A1 (en) *	2008-01-29	2009-08-19	Sanofi-Aventis	Substituted heteroarylamide diazepinopyrimidone derivatives
EP2090578A1 (en) *	2008-01-29	2009-08-19	Sanofi-Aventis	Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
EP2085400A1 (en) *	2008-01-29	2009-08-05	Sanofi-Aventis	Substituted heteroarylamide oxazepinopyrimidone derivatives
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP6974331B2 (ja) *	2016-02-05	2021-12-01	デナリセラピューティクスインコーポレイテッドDenali Therapeutics Inc.	化合物、組成物及び方法
CN108164548B (zh) *	2016-12-07	2020-09-08	四川大学	嘧啶并吗啉衍生物及其制备方法和用途
RS63203B1 (sr)	2016-12-09	2022-06-30	Denali Therapeutics Inc	Jedinjenja korisna kao inhibitori ripk1
IL314082A (en)	2022-01-12	2024-09-01	Denali Therapeutics Inc	Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG13192A (en)	1976-02-10	1982-12-31	Rhone Poulenc Ind	Nouveaux derives du dithiole-1,2 leur preparation et les compositions qui les contiennent
US5629322A (en)	1994-11-15	1997-05-13	Merck & Co., Inc.	Cyclic amidine analogs as inhibitors of nitric oxide synthase
CA2234641A1 (en)	1995-11-01	1997-05-09	Merck & Co., Inc.	Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
US20030096813A1 (en) *	2001-04-20	2003-05-22	Jingrong Cao	Compositions useful as inhibitors of GSK-3
CA2457952C (en)	2001-09-21	2009-11-10	Sanofi-Synthelabo	Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
EP1557417B1 (en)	2003-12-19	2007-03-07	Sanofi-Aventis	Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
EP1790649A1 (en)	2005-11-21	2007-05-30	Sanofi-Aventis	Substituted bicyclic pyrimidone derivatives
EP2090579A1 (en)	2008-01-29	2009-08-19	Sanofi-Aventis	Substituted heteroarylamide diazepinopyrimidone derivatives
EP2090578A1 (en)	2008-01-29	2009-08-19	Sanofi-Aventis	Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
EP2085400A1 (en) *	2008-01-29	2009-08-05	Sanofi-Aventis	Substituted heteroarylamide oxazepinopyrimidone derivatives

2008
- 2008-01-29 EP EP08290075A patent/EP2085399A1/en not_active Withdrawn
2009
- 2009-01-19 TW TW098101926A patent/TW200936140A/zh unknown
- 2009-01-27 NZ NZ587067A patent/NZ587067A/en not_active IP Right Cessation
- 2009-01-27 AR ARP090100240A patent/AR070263A1/es unknown
- 2009-01-27 WO PCT/IB2009/000298 patent/WO2009095788A1/en not_active Ceased
- 2009-01-27 KR KR1020107016902A patent/KR20100117582A/ko not_active Withdrawn
- 2009-01-27 CA CA2713253A patent/CA2713253A1/en not_active Abandoned
- 2009-01-27 EA EA201070890A patent/EA201070890A1/ru unknown
- 2009-01-27 BR BRPI0906357-9A patent/BRPI0906357A2/pt not_active IP Right Cessation
- 2009-01-27 MX MX2010008361A patent/MX2010008361A/es not_active Application Discontinuation
- 2009-01-27 JP JP2010544813A patent/JP5581221B2/ja not_active Expired - Fee Related
- 2009-01-27 AU AU2009208727A patent/AU2009208727A1/en not_active Abandoned
- 2009-01-27 CN CN2009801065335A patent/CN101959893A/zh active Pending
- 2009-01-27 EP EP09706539A patent/EP2247599B1/en active Active
2010
- 2010-07-26 IL IL207231A patent/IL207231A0/en unknown
- 2010-07-27 US US12/844,275 patent/US8507470B2/en not_active Expired - Fee Related
- 2010-07-28 ZA ZA2010/05383A patent/ZA201005383B/en unknown

Also Published As

Publication number	Publication date
KR20100117582A (ko)	2010-11-03
CA2713253A1 (en)	2009-08-06
AU2009208727A1 (en)	2009-08-06
US20110015177A1 (en)	2011-01-20
EP2247599B1 (en)	2012-11-28
EA201070890A1 (ru)	2011-02-28
AR070263A1 (es)	2010-03-25
NZ587067A (en)	2011-11-25
JP5581221B2 (ja)	2014-08-27
JP2011510969A (ja)	2011-04-07
US8507470B2 (en)	2013-08-13
ZA201005383B (en)	2011-10-26
EP2247599A1 (en)	2010-11-10
IL207231A0 (en)	2010-12-30
EP2085399A1 (en)	2009-08-05
CN101959893A (zh)	2011-01-26
WO2009095788A1 (en)	2009-08-06
MX2010008361A (es)	2010-08-30
TW200936140A (en)	2009-09-01

Publication	Publication Date	Title
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
ATE555107T1 (de)	2012-05-15	2-aza-bicyclo-ä2,2,1-üheptan-derivate
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
BRPI0813707A2 (pt)	2014-12-30	Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0909527A2 (pt)	2019-09-24	derivados substituídos de 4-aminociclohexano
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
EP2376493A4 (en)	2012-05-30	DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en)	2012-06-27	PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
BRPI0906357A2 (pt)	2015-07-07	Derivados de oxazepinopirimidona arilamida substituídos
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
BRPI0812518A2 (pt)	2015-03-31	Derivados de indazolamida
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
EP2336132A4 (en)	2012-03-21	MORPHOLINPURINDERIVAT
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.